PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc., a leading AI technology platform provider for clinical research, today announced that Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the Morgan Stanley Global Healthcare Conference in New York City. The presentation will take place on Tuesday, September 9th 7:45 AM Eastern Time.
About Medable
Medable, a Software as a Service (SaaS) cloud platform, is revolutionizing clinical drug development. Our AI-driven platform, including Agent Studio, enhances speed, scale, and patient access in clinical research. Awarded Best Digital Health Solution by the Galien Foundation, Medable’s platform has been deployed in nearly 400 trials in 70 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and was listed for the second year in a row on the Inc. 5000 in 2024.
Contacts
Media Contact:
Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
[email protected] / [email protected]
Burak Over, SVP, Corporate Development & Investor Relations, Medable
[email protected]
